DiVincenzo Jonathan P. — SEC Form 4 filings
SEC reporting owner CIK 1453524. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-06 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 500 shares, $107,745 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 500 shares @ $215.49 ($107,745) in LABORATORY CORP OF AMERICA HOLDINGS, filed 2024-02-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LABORATORY CORP OF AMERICA HOLDINGS (LH) | EVP, Pres, Central Labs & Intl | 5 | — | 1 leg · 500 sh · $107,745 | 17 |
| BIO-RAD LABORATORIES, INC. | President & COO | 5 | — | — | 10 |
Form 4 filings — DiVincenzo Jonathan P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | BIO-RAD LABORATORIES, INC. | Option exercise (M): 1,712 @ $0 · Tax withholding (F): 668 @ $386.11 · Grant/award (A): 6,326 (derivative) @ $0 · Option exercise (M): 1,712 (derivative) @ $0 | EDGAR |
| 2025-10-28 | 4 | BIO-RAD LABORATORIES, INC. | Option exercise (M): 1,869 @ $0 · Tax withholding (F): 950 @ $339.75 · Option exercise (M): 1,869 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | BIO-RAD LABORATORIES, INC. | Grant/award (A): 6,850 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | BIO-RAD LABORATORIES, INC. | Grant/award (A): 4,863 (derivative) @ $0 | EDGAR |
| 2024-10-25 | 4 | BIO-RAD LABORATORIES, INC. | Grant/award (A): 7,478 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 3,012 · Tax withholding (F): 952 @ $216.57 · Option exercise (M): 3,012 (derivative) | EDGAR |
| 2024-02-22 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Sale (S): 500 @ $215.49 | EDGAR |
| 2024-02-13 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 201 · Tax withholding (F): 59 @ $227.45 · Option exercise (M): 201 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 224 · Tax withholding (F): 78 @ $223.71 · Option exercise (M): 138 · Tax withholding (F): 41 @ $223.71 · Grant/award (A): 980 (derivative) @ $0 · Grant/award (A): 3,000 (derivative) @ $0 · +2 more | EDGAR |
| 2024-02-06 | 4 | LABORATORY CORP OF AMERICA HOLDINGS (LH) | Option exercise (M): 246 · Tax withholding (F): 85 @ $221.54 · Option exercise (M): 246 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1453524 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →